Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Molecular targeting of BCL2 and BCLXL proteins by synthetic BCL2 homology 3 domain peptide enhances the efficacy of chemotherapy.

Dharap SS, Chandna P, Wang Y, Khandare JJ, Qiu B, Stein S, Minko T.

J Pharmacol Exp Ther. 2006 Mar;316(3):992-8. Epub 2005 Nov 15.

PMID:
16291730
2.

Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.

Yu D, Peng P, Dharap SS, Wang Y, Mehlig M, Chandna P, Zhao H, Filpula D, Yang K, Borowski V, Borchard G, Zhang Z, Minko T.

J Control Release. 2005 Dec 10;110(1):90-102. Epub 2005 Nov 4.

PMID:
16271793
3.

Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.

Dharap SS, Wang Y, Chandna P, Khandare JJ, Qiu B, Gunaseelan S, Sinko PJ, Stein S, Farmanfarmaian A, Minko T.

Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12962-7. Epub 2005 Aug 25.

4.

Molecular targeting of drug delivery systems to cancer.

Minko T, Dharap SS, Pakunlu RI, Wang Y.

Curr Drug Targets. 2004 May;5(4):389-406. Review.

PMID:
15134222
5.

Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides.

Dharap SS, Qiu B, Williams GC, Sinko P, Stein S, Minko T.

J Control Release. 2003 Aug 28;91(1-2):61-73.

PMID:
12932638
6.

Targeted proapoptotic LHRH-BH3 peptide.

Dharap SS, Minko T.

Pharm Res. 2003 Jun;20(6):889-96.

PMID:
12817893
7.

Enhancing the efficacy of chemotherapeutic drugs by the suppression of antiapoptotic cellular defense.

Minko T, Dharap SS, Fabbricatore AT.

Cancer Detect Prev. 2003;27(3):193-202.

PMID:
12787726

Supplemental Content

Loading ...
Support Center